Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 288 | 325 | 314 | 255 | 298 |
| Operating Income | -288 | -325 | -314 | -255 | -298 |
| Other Income | 2,100 | 3,197 | 2,544 | 1,333 | 419 |
| Pre-tax Income | 1,812 | 2,872 | 2,230 | 1,077 | 121 |
| Net Income Continuous | 1,812 | 2,872 | 2,230 | 1,077 | 121 |
| Net Income | $1,812 | $2,872 | $2,230 | $1,077 | $121 |
| EPS Basic Total Ops | 3.60 | 3.20 | 3.60 | 1.20 | 0.00 |
| EPS Basic Continuous Ops | 19.31 | 15.99 | 12.41 | 5.99 | 0.67 |
| EPS Diluted Total Ops | 3.60 | 3.20 | 3.60 | 1.20 | 0.00 |
| EPS Diluted Continuous Ops | 19.31 | 15.99 | 12.41 | 5.99 | 0.67 |
| EBITDA(a) | $-288 | $-325 | $-314 | $-255 | $-298 |